Medvok Medical
1 / 5
| Certification | CE, FDA, ISO13485 |
| Group | All People |
| Scanning Speed | < 40s (15mm*15mm 20X) |
| Focusing Method | Autofocus |
| Barcode Recognition | Support |
| Image Format | Multiple |
| AI Support | Integration Support |
| Remote Consultation | Support |
| HS Code | 9027899090 |
The automatic digital pathology analysis and scanning system is a new generation of automatic intelligent diagnosis equipment based on array scanning technology. It adopts positioning needle technology for accurate positioning. Equipped with 0.5 times switching mirror, larger imaging field of vision, faster scanning speed, and a double camera structure. The region recognition function and variety of models can meet the needs of different grades of hospitals and institutions.
| Feature | Specification |
|---|---|
| Workstation | Core i7, 3060TI, 16G+2T |
| Product Model | S240A / S120A / VC240A / C120A |
| Lighting Source | LED Light Source |
| Scanning Method | Area Array Scanning |
| Objective Lens | 0.75 Numerical Aperture |
| Motion Control | Six-axis Control System |
| Scanning Magnification | 4x / 10x / 20x / 40x |
| Resolution | 0.46 μm/pixel (20x) / 0.23 μm/pixel (40X) |
• Alleviate the current situation of insufficient medical resources at the grassroots level and in remote areas.
• Effectively integrating cellular pathology expert resources to improve overall diagnostic quality.
• Train grassroots medical personnel to improve their diagnostic skills via shared digital cases.
Products include research, development, production, and sales of high-end medical devices such as fluorescence imaging series, fluorescence contrast agent drugs (ICG, targeted contrast agents), and core components like fluorescence CMOS camera modules and endoscopes.
Focusing on core technologies such as molecular fluorescence, Raman spectroscopy, AI, computer-aided drug molecular design (CADD), and AI-assisted drug design. The mission is to become a global leader in molecular fluorescence technology through the synergy of medical devices and pharmaceuticals.
As a specialized "little giant" enterprise, we have undertaken national and provincial key research projects, holding 131 core invention patents and 7 US invention patents.
Strategically partnered with international leading companies in Germany and Japan, establishing cooperative businesses with more than 10 overseas countries.
